COMMUNIQUÉS West-GlobeNewswire

Alkahest Strengthens Executive Leadership with Appointment of Robert Klein as Chief Business Officer
24/07/2019
SAN CARLOS, Calif., July 24, 2019 (GLOBE NEWSWIRE) -- Alkahest, Inc., a clinical-stage biotechnology company focused on developing innovative therapies to treat age-related diseases, today announced the appointment of [...]
Cognition Therapeutics Extends IP Coverage of Alzheimer’s Therapeutic Elayta™ to Additional Major Pharmaceutical Markets with Patent Issuances in Japan and China
24/07/2019
Pittsburgh, July 24, 2019 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. , a clinical stage neuroscience company focused on the protection and restoration of synaptic function in Alzheimer’s disease and other [...]
Rezolute Completes $45 Million Investment Round with Full Exercise of $20 Million Option
24/07/2019
REDWOOD CITY, Calif., July 24, 2019 (GLOBE NEWSWIRE) -- Rezolute, Inc. (“Rezolute”) (OTCQB:RZLT), a clinical stage biopharmaceutical company specializing in the development of transformative therapies targeting [...]
Adamis Pharmaceuticals Provides Update on Litigation with Belcher Pharmaceuticals
24/07/2019
SAN DIEGO, July 24, 2019 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) (“Adamis”) announced today that Adamis and Belcher Pharmaceuticals, LLC (“Belcher”) agreed to settle all previously filed [...]
Obalon Announces Reverse Stock Split Effective Today
24/07/2019
OBLN common stock expected to begin trading on a split-adjusted basis on July 25, 2019 SAN DIEGO, July 24, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ), a vertically integrated medical technology [...]
B. Braun Successfully Integrates with TeleTracking
24/07/2019
BETHLEHEM, Pa., July 24, 2019 (GLOBE NEWSWIRE) -- B. Braun Medical Inc. announced the integration of their Space Infusion Pump Systems with TeleTracking Technologies, Inc.’s RTLS Asset Tracking solution. “The successful [...]
Cannabix Technologies Achieves THC Breath Capture Milestone, Comments on Patent Portfolio
24/07/2019
The Cannabix Marijuana Breathalyzer is being developed to provide law enforcement and employers a tool to enforce public safety VANCOUVER, British Columbia, July 24, 2019 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. ( [...]
Study Published in American Health Drug Benefits Suggests that Non-Invasive Screening Methods, Including Epi proColon®, Could Be A Cost-Effective Option To Help Achieve Target U.S. Colorectal Cancer Screening Rates
24/07/2019
BERLIN, July 24, 2019 (GLOBE NEWSWIRE) -- Epigenomics AG (FSE: ECX, OTCQX: EPGNY; the “Company”), a molecular diagnostics company focused on blood-based detection of cancers using its proprietary DNA methylation [...]
BioTelemetry, Inc. Acquires Sweden-based ADEA Medical AB and Expands International Service Offering
24/07/2019
MALVERN, Pa., July 24, 2019 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of [...]
Novan’s Drug Substance Demonstrates Inhibition of HPV-18 Virus Production
24/07/2019
Preclinical data published in Antiviral Research Study conducted by Drs. N.S. Banerjee, L.T. Chow and T.R. Broker at The University of Alabama at Birmingham Findings reinforce anti-viral mechanism of action for Novan’s [...]
Ziopharm Oncology Names Sath Shukla as Chief Financial Officer
24/07/2019
Joins from Vertex Pharmaceuticals; Served as global Head of Corporate Finance BOSTON, July 24, 2019 (GLOBE NEWSWIRE) -- Ziopharm Oncology , Inc. (“Ziopharm” or “the Company”) (Nasdaq:ZIOP), a clinical stage immuno- [...]
Foamix Pharmaceuticals to Report Second Quarter 2019 Financial Results on August 8
24/07/2019
REHOVOT, Israel, and BRIDGEWATER, N.J., July 24, 2019 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX), (“Foamix”), a clinical-stage pharmaceutical company that specializes in developing and [...]
Miragen Therapeutics to Report Second Quarter 2019 Financial Results and Host a Conference Call on August 7th
24/07/2019
BOULDER, Colo., July 24, 2019 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company developing proprietary RNA-targeted therapies with a specific focus on microRNAs, [...]
HTG Molecular Diagnostics to Announce Second Quarter 2019 Financial Results and Host Conference Call on Tuesday, August 6
24/07/2019
TUCSON, Ariz., July 24, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM), a diagnostic company whose mission is to advance precision medicine, today announced that it will report its financial [...]
Surgery Partners, Inc. Announces Second Quarter 2019 Earnings Release Date and Conference Call Details
24/07/2019
NASHVILLE, Tenn., July 24, 2019 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced that the Company will release its [...]
Mustang Bio Receives Orphan Drug Designation for MB-102 (CD123 CAR T) for the Treatment of Acute Myeloid Leukemia
24/07/2019
NEW YORK, July 24, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO ), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into [...]
Synthorx Initiates Patient Dosing in Australia and Announces Clearance of IND in the U.S. for Lead Immuno-oncology Product Candidate, THOR-707
24/07/2019
SAN DIEGO, July 24, 2019 (GLOBE NEWSWIRE) -- Synthorx, Inc. (NASDAQ: THOR), a clinical-stage biotechnology company developing optimized therapeutics for cancer and autoimmune disorders, announced today it has opened [...]
Chembio Diagnostics to Report Second Quarter 2019 Financial Results on August 6, 2019
24/07/2019
MEDFORD, N.Y., July 24, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will release financial [...]
Rhythm Pharmaceuticals Announces Appointment of Stuart Arbuckle to its Board of Directors
24/07/2019
BOSTON, July 24, 2019 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq:RYTM), a biopharmaceutical company focused on the development and commercialization of therapeutics for the treatment of rare genetic [...]

Pages